Close
CDMO Safety Testing 2026
Novotech

Tag: Acquisition

Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline

Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its...

CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase

CVC reaffirms confidence in Syntegon's strategic direction and continued growth potential Apollo acquires 37% minority stake and adds valuable expertise โ€“ particularly to...

Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach

In order to broaden its portfolio in imaging and cardiovascular medicine, Bayer has agreed to purchase two experimental diagnostic imaging agents from Attralus. The...

Amgen Eyeing Preclinical Blood Cancer Program to Its Skills

Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program ofย U.K. biotechย into its organization. The California pharma has...

J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn

Johnson & Johnson - J&J has completed theย acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This...

Celltrion Eyes Full-Scale Contract Manufacturing Operations

Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly thatโ€™s located in Branchburg,...

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate ยป